WestEnd Advisors’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$556 Buy
35
+4
+13% +$62 ﹤0.01% 334
2026
Q1
$419 Hold
31
﹤0.01% 324
2025
Q4
$386 Sell
31
-3
-9% -$32 ﹤0.01% 330
2025
Q3
$337 Sell
34
-17
-33% -$165 ﹤0.01% 345
2025
Q2
$455 Buy
51
+5
+11% +$42 ﹤0.01% 286
2025
Q1
$401 Buy
46
+30
+188% +$315 ﹤0.01% 292
2024
Q4
$199 Buy
16
+3
+23% +$37 ﹤0.01% 258
2024
Q3
$151 Sell
13
-2
-13% -$23 ﹤0.01% 324
2024
Q2
$159 Sell
15
-5
-25% -$55 ﹤0.01% 283
2024
Q1
$239 Buy
20
+2
+11% +$24 ﹤0.01% 233
2023
Q4
$195 Buy
18
+1
+6% +$10 ﹤0.01% 238
2023
Q3
$168 Buy
+17
New +$177 ﹤0.01% 241
2023
Q1
Sell
-14
Closed -$155 257
2022
Q4
$156 Sell
14
-2
-13% -$21 ﹤0.01% 249
2022
Q3
$0 Buy
16
+1
+7% +$10 ﹤0.01% 327
2022
Q2
$157 Buy
+15
New +$164 ﹤0.01% 237
2022
Q1
Sell
-9
Closed -$119 276
2021
Q4
$121 Buy
+9
New +$120 ﹤0.01% 324
2021
Q3
Hold
0
309
2021
Q2
Hold
0
290

Other funds holding VTRS

WestEnd Advisors's VTRS Position: Q2 2026 in Review

WestEnd Advisors increased its Viatris (VTRS) stake by 13% in Q2 2026, buying an estimated $62 and bringing the position to 35 shares worth $556. The position accounts for ﹤0.01% of the portfolio, ranked #334.

WestEnd Advisors first reported a position in VTRS in Q4 2021 and has held it in 16 quarters since. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • WestEnd Advisors held 35 shares of Viatris worth $556 as of Q2 2026.
  • WestEnd Advisors bought 4 Viatris shares in Q2 2026, an estimated $62.
  • Viatris made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #334 holding.
  • WestEnd Advisors first reported a position in Viatris in Q4 2021 and has held it in 16 quarters since.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.